Abstract:Inspired by the emergence of resistance to currently available antifungal therapy and by the great potential of metal complexes for the treatment of various diseases, we synthesized three new silver(I) complexes containing clinically used antifungal azoles as ligands, [Ag(ecz)2]SbF6 (1, ecz is econazole), {[Ag(vcz)2]SbF6}n (2, vcz is voriconazole), and [Ag(ctz)2]SbF6 (3, ctz is clotrimazole), and investigated their antimicrobial properties. The synthesized complexes were characterized by mass spectrometry, IR, UV-Vis and 1H NMR spectroscopy, cyclic voltammetry, and single-crystal X-ray diffraction analysis. In the mononuclear complexes 1 and 3 with ecz and ctz, respectively, the silver(I) ion has the expected linear geometry, in which the azoles are monodentately coordinated to this metal center through the N3 imidazole nitrogen atom. In contrast, the vcz-containing complex 2 has a polymeric structure in the solid state in which the silver(I) ions are coordinated by four nitrogen atoms in a distorted tetrahedral geometry. DFT calculations were done to predict the most favorable structures of the studied complexes in DMSO solution. All the studied silver(I) complexes have shown excellent antifungal and good to moderate antibacterial activities with minimal inhibitory concentration (MIC) values in the ranges of 0.01 – 27.1 and 2.61 – 47.9 μM on the selected panel of fungi and bacteria, respectively. Importantly, the complexes 1 – 3 have exhibited a significantly improved antifungal activity compared to the free azoles, with the most pronounced effect observed in the case of complex 2 compared to the parent vcz against Candida glabrata with an increase of activity by five orders of magnitude. Moreover, the silver(I)-azole complexes 2 and 3 significantly inhibited the formation of C. albicans hyphae and biofilms at the subinhibitory concentration of 50% MIC. To investigate the impact of the complex 3 more thoroughly on Candida pathogenesis, its effect on the adherence of C. albicans to A549 cells (human adenocarcinoma alveolar basal epithelial cells), as an initial step of the invasion of host cells, was studied.

Synthesis, crystal structures and in vitro anti-fungal activities of two silver(I) coordination polymers with fluconazole

Synthesis, crystal structure and in vitro antifungal activity of two-dimensional silver(I)-voriconazole coordination complexes

Synthesis, Structural Characterization, Hirshfeld Surface, DFT Calculation and Antifungal Activity of Novel Quinoline Carbonothioate Compounds

Novel Potentially Antifungal Hybrids of 5-Flucytosine and Fluconazole: Design, Synthesis and Bioactive Evaluation.

Synthesis, Crystal Structures and Properties of Novel Zinc(ii) and Cadmium(ii) Polymeric and Cyclic Bimetallic Complexes with Fluconazole and Dicarboxylate Co-Ligands

Silver(I) complexes containing antifungal azoles: Significant improvement of the anti-Candida potential of the azole drug after its coordination to the silver(I) ion

Anion-tuned Self-Assembly of Zinc(ii)–fluconazole Complexes: Crystal Structures, Luminescent and Thermal Properties

Synthesis, crystal structure and in vitro antibacterial activity of two novel silver(I) complexes

Syntheses, crystal structures and antimicrobial activities of polynuclear CoII, NiII and ZnII complexes derived from the N,N'-bis(4-fluorosalicylidene)-1,3-propanediamine Schiff base

Anion-directed Supramolecular Assembly of Cobalt(ii)-Fluconazole Coordination Polymers: Structural Diversity, Fluorescent and Magnetic Properties

Silver complexes with sulfathiazole and sulfamethoxazole: Synthesis, spectroscopic characterization, crystal structure and antibacterial assays

Syntheses, Crystal Structures and Antibacterial Activities of Copper(Ii) and Zinc(Ii) Complexes Based on (E)-4-fluoro-2-((3-morpholinopropylimino)methyl)phenol

Silver(I) complexes with voriconazole as promising anti- Candida agents

Thiocyanate-induced Conformational Transformation of a Flexible Fluconazole Ligand in Cd(II) Coordination Polymers

Synthesis, Molecular Docking, and Biological Evaluation of Novel Triazole Derivatives as Antifungal Agents

Cyclometalated iridium(III) complexes combined with fluconazole: antifungal activity against resistant C. albicans

Synthesis, Crystal Structure and Antimicrobial Activities of A Novel Schiff Base Zinc(Ii) Complex

Two Novel 2d Waves Copper(Ii) Coordination Polymer with the Quinolone Antimicrobial Drugs Ciprofloxacin: Synthesis, Structure and Biological Evaluation

A novel 2D coordination polymer with unprecedented [Ag]7 chains and two 3D silver-organic frameworks constructed by methylenediisophthalic acid (H4MDIP) with strong Ag-Ag interactions

2D and 3D Silver(I)-Ethylenediamine Coordination Polymers with Ag–Ag Argentophilic Interactions

Strong Silver-Silver Interactions in Three Silver(I) Carboxylate Complexes with High Cytotoxicity Properties